Dividends Calendar Earnings Calendar
NTLA

NTLA | Intellia Therapeutics Inc

Intellia Therapeutics Inc
Category: Biotechnology company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Cambridge, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 10B
  • Prev closed: 13.36
  • Open: 13.87
  • High: 13.91
  • Low: 13.37
  • 52 week low: 9.18
  • 52 week high: 19
  • Dividends:No Dividends

Next ER: November 4, 2021  Before Market Opens



Top Stories (NTLA)

    About the Company

    Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 16, 2022
    November 4, 2021-0.97 / -0.84717.2M / 8.66M
    August 5, 2021-1.01 / -0.63426.55M / 12.21M
    May 6, 2021-0.69 / -0.65796.45M / 9.86M
    February 25, 2021-0.69 / -0.60256.6M / 13.14M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jan 13, 2022 90.20 97.89
    99.07
    89.21
    1.28M -8.06%
    Jan 12, 2022 98.11 106.62
    107.99
    97.72
    877.48K -6.77%
    Jan 11, 2022 105.24 104.93
    107.49
    100.97
    654.00K 0.97%
    Jan 10, 2022 104.23 103.26
    105.32
    99.51
    938.45K -1.43%
    Jan 7, 2022 105.74 103.87
    112.89
    102.26
    740.07K 1.12%
    Jan 6, 2022 104.57 102.99
    106.91
    96.93
    1.16M 1.18%
    Jan 5, 2022 103.35 112.06
    113.22
    102.92
    1.21M -8.97%
    Jan 4, 2022 113.54 118.99
    119.23
    108.09
    1.08M -4.58%
    Jan 3, 2022 118.99 118.28
    119.65
    112.72
    537.18K 0.63%
    Dec 31, 2021 118.24 121.09
    126.81
    118.03
    365.57K -2.47%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:104

    News

    News for (NTLA)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Nessan Bermingham, PhD
    • General Counsel :  José Rivera

    Talk about Intellia Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 4, 2021 (Same day)

    fslr sq w y dk meli eog lng dish viab tef feye 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 73
    HOLD 27
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInInstagram

    Peers / Similar stocks 

    xlv 

    Other stocks 

    ibm tgt aap sig pdco azo tvpt low afsi amg cgc docu 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis